Connectome Is Making Brain Function Measurable in Real Time
The Missing Metric in Health: Measuring the Brain
For decades, healthcare has steadily moved toward quantification. We track heart rate, sleep cycles, glucose levels, and physical activity with increasing precision. Wearables and digital health platforms have turned the human body into a stream of measurable signals, enabling earlier interventions and more personalized care.
Yet one critical dimension of health has remained largely invisible: the brain.
Cognitive performance, mental fatigue, focus, and early signs of decline are still difficult to measure objectively and consistently. Most assessments rely on subjective reporting, periodic testing, or clinical evaluations that capture only snapshots in time. This gap has limited our ability to understand how the brain changes day to day, how lifestyle factors influence cognitive performance, and how early signs of neurological conditions might emerge.
Connectome, a Zurich and London-based neurotechnology startup, is attempting to change that by making brain function measurable, repeatable, and trackable over time.
Why Cognitive Change Has Been Hard to Track?
The challenge of measuring brain function is both technical and practical. Traditional neuroimaging tools such as MRI and CT scans provide detailed insights into brain structure and activity, but they are expensive, immobile, and unsuitable for frequent use. As a result, cognitive health has largely been assessed through indirect methods. These include behavioral tests, questionnaires, and clinical observations, all of which provide limited resolution and are often influenced by external factors.
More importantly, these approaches do not allow for continuous monitoring. They capture isolated moments rather than trends, making it difficult to detect subtle changes or patterns over time. In contrast to physical health metrics, which can be tracked daily or even continuously, cognitive health has remained episodic and reactive.
Inside Connectome’s Approach: Measuring Brain Function Over Time
Connectome’s platform is built around the idea that brain function can be measured in a repeatable and scalable way. At the core of its technology is functional near-infrared spectroscopy (fNIRS), a non-invasive neuroimaging technique that measures changes in blood oxygenation in the brain.
Unlike traditional imaging methods, fNIRS devices are portable and can be used more frequently, enabling longitudinal tracking of brain activity. This allows for the collection of data over extended periods, providing insights into how cognitive function evolves.
Connectome combines this measurement capability with artificial intelligence models that interpret brain signals in the context of real-world data. This includes lifestyle factors, biometrics, and behavioral patterns, creating a more comprehensive picture of cognitive health.
The result is not just raw data, but a system that can detect changes, identify trends, and provide insights at an individual level. Connectome is not just measuring the brain. It is making cognitive change observable over time.
From Measurement to Meaning: Building a Cognitive Data Layer
The significance of Connectome’s approach lies in its ability to transform brain activity into actionable data. Measuring brain signals is only the first step; interpreting those signals in a meaningful way is where the real value lies. By combining neuroimaging with AI-driven analysis, the platform creates a cognitive data layer that can be integrated into various applications. This includes performance optimization, clinical monitoring, and research.
For example, organizations can use this data to understand how employees’ cognitive performance fluctuates under different conditions. Clinics can monitor patients over time to detect early signs of cognitive decline. Researchers can gain insights into how different interventions affect brain function. This shift from measurement to meaning represents a broader trend in health technology, where data is increasingly used to drive decision-making and personalization. If wearables quantified the body, platforms like Connectome aim to quantify the mind.
Applications Across Performance, Clinics, and Research
Connectome’s platform is designed to operate across multiple domains, each with its own set of use cases. In performance settings, the technology can be used to monitor focus, fatigue, and cognitive load. This has applications in high-performance environments such as sports, corporate settings, and other areas where mental performance is critical.
In clinical contexts, the platform enables longitudinal tracking of brain health. This can support early detection of neurological conditions, as well as ongoing monitoring of treatment outcomes. In research, the ability to collect large-scale, real-world brain data opens up new possibilities for understanding cognition. Researchers can study how different variables affect brain function over time, leading to more robust and generalizable findings.
By addressing these diverse use cases, Connectome positions itself as a foundational platform for cognitive measurement.
The Rise of Continuous Cognitive Health Monitoring
The broader implication of Connectome’s work is the emergence of continuous cognitive health monitoring. As technology advances, the ability to track brain function in real time may become as commonplace as tracking physical activity. This shift could fundamentally change how we approach mental health and cognitive performance. Instead of reacting to problems after they arise, individuals and organizations could identify issues early and take proactive steps.
Continuous monitoring also enables a more personalized approach to health. By understanding how cognitive performance varies from person to person, interventions can be tailored to individual needs. However, this evolution also raises important questions around data privacy, ethical use, and the interpretation of complex neurological data. Ensuring that these systems are used responsibly will be a key challenge for the industry.
Connectome Secures €1.7 Million to Scale Cognitive Measurement Platform
Connectome has recently raised approximately €1.7 million ($2 Million) in a pre-seed funding round to support the development and scaling of its platform. The investment will be used to advance its technology, expand its applications, and bring its cognitive measurement capabilities to a broader audience.
The funding reflects growing interest in neurotechnology solutions that enable early detection and personalized insights. As the importance of cognitive health becomes more widely recognized, platforms that can provide measurable and actionable data are attracting attention from investors and industry stakeholders. While the funding is relatively early-stage, it signals confidence in Connectome’s vision of making brain function a measurable and trackable aspect of health.
What Comes Next for Cognitive Health Infrastructure?
Connectome’s approach represents a step toward a new kind of health infrastructure, one that includes the brain as a measurable and continuously monitored system. As technology continues to evolve, the integration of cognitive data into broader health ecosystems may become increasingly important. The ability to measure and understand brain function at scale has implications not only for healthcare but also for productivity, education, and human performance.
As with other areas of health technology, the success of this approach will depend on its ability to deliver meaningful insights, integrate with existing systems, and maintain trust among users. The development of platforms like Connectome suggests that the future of health may be defined not just by how we treat the body, but by how we understand and optimize the mind. The emergence of platforms like Connectome marks a significant shift toward making cognitive health measurable and actionable, potentially transforming how individuals and organizations approach brain performance and long-term neurological well-being.